active: true
address:
    address1: 1000 SPRING ST
    city: SILVER SPRING
    postal_code: '20910'
    state: MD
branding:
    logo_url: https://api.polygon.io/v1/reference/company-branding/dW5pdGhlci5jb20/images/2025-04-04_logo.svg
cik: 0001082554
composite_figi: BBG000BV4XJ1
currency_name: usd
description: 'United Therapeutics Corp specializes in drug development for pulmonary
    arterial hypertension (PAH), a rare and progressive disease marked by abnormally
    high blood pressure in the arteries of the lungs. The company''s therapies for
    PAH largely focus on the prostacyclin pathway, and many of its treatments are
    based on the same molecule, treprostinil. The company markets and sells the following
    commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil)
    Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release
    Tablets, Adcirca (tadalafil) Tablets, and Unituxin. In addition, it is developing
    a pipeline of projects that includes new indications and delivery devices for
    existing products and new products to treat PAH and other conditions.'
homepage_url: https://www.unither.com
list_date: '1999-06-17'
locale: us
market: stocks
market_cap: 14007477866.640001
name: United Therapeutics Corp
phone_number: (301) 608-9292
primary_exchange: XNAS
round_lot: 100
share_class_figi: BBG001S8RV10
share_class_shares_outstanding: 45106623
sic_code: '2834'
sic_description: PHARMACEUTICAL PREPARATIONS
ticker: UTHR
ticker_root: UTHR
total_employees: 1305
type: CS
weighted_shares_outstanding: 45226262
